fda semaglutide warning november 2025 Beyond the Headlines: Letters to GLP-1 Compounders Compounded "semaglutide" is not FDA-approved
Description
PlexusDx clinicians monitor your response at each check-in and can adjust your treatment plan if side effects outweigh benefits
The story of GLP-1 therapy over the past decade has been one of the most rapid and consequential transformations in the history of metabolic medicine, moving from incretin-based diabetes management to a class of drugs that reduce cardiovascular events, appear to slow neurodegeneration, and now achieve weight loss magnitudes that rival bariatric surgery
Small shifts in food, hydration, and activity can go a long way in making you feel warm-blooded againblanket optional.
Advanced Weight Loss & Glycemic Benefits
Nausea is most common when starting the medication or increasing the dose, but it typically improves as the body adjusts over time
